Table 2.

Adverse events observed during 2-yr follow-upa

Adverse EventNo. of Events
Control GroupIDPN Group
Event
Deaths3640
    heart failure108
    stroke78
    infection87
    cancer17
Other causes1010
Hospitalizations for arteriovenous care6454
    vascular access thrombosis1010
Hospitalization for other reasons180180
Events inducing discontinuation of IDPN11
Nausea and vomiting3446
Diarrhea148
Abdominal pain98
Increase in plasma triglycerides >2 mmol/L28
Increase in serum ALAT >1 N10
Increase in serum GGT >1 N19
  • a Some patients had more than one event.